Analysis of CNVs on TIDE showed longer survival in patients with higher CD74 CNVs in glioma, LIHC, and DLBC but reduced survival in TNBC, LUAD, and SKCM (Fig. 3C). The gene discussed is CD74; the disease is central nervous system cancer.